Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000171255 | SCV003443074 | uncertain significance | not provided | 2022-05-04 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 117 of the GPR179 protein (p.Asp117Asn). This variant is present in population databases (rs776996552, gnomAD 0.007%). This missense change has been observed in individual(s) with clinical features of GPR179-related conditions (PMID: 26355662). ClinVar contains an entry for this variant (Variation ID: 191075). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Center for Genomic Medicine, |
RCV003989479 | SCV004807731 | uncertain significance | Congenital stationary night blindness 1E | 2024-03-29 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000171255 | SCV000221452 | likely pathogenic | not provided | flagged submission | research |